Case-control studyindependent cross-checkabstract checked★ key study I-GRN-103 in-depth review

Some people with wheat sensitivity show signs of gut damage in blood tests

Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease.

Overview

Uhde M et al.. Gut 2016 · PMID 27459152 · DOI 10.1136/gutjnl-2016-311964

People who react to wheat without coeliac disease had higher markers of immune activation and gut-cell damage, which improved off wheat in a subgroup.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Look for objective signs in wheat sensitivity.

How was the study done?

Blood biomarkers compared between groups.

How many people, animals or samples were studied?

Wheat-sensitive people, coeliac patients, healthy controls (numbers not in abstract).

What was actually found?

Higher immune and gut-damage markers in the wheat-sensitive group.

How large was the observed effect?

Not quantified in abstract.

What do the results mean in everyday life?

A subgroup may have a real biological reaction to wheat.

What are the study's limitations?

Not blinded; not replicated at scale.

What does it say about Elawady's specific claim?

Contradicts the idea that wheat sensitivity does not exist at all.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Cannot show that gluten itself is the trigger or how many people are affected.

Scientific in-depth review

1. Full reference

Authors
Uhde M et al.
Journal
Gut
Year
2016
Identifier
PMID 27459152 DOI 10.1136/gutjnl-2016-311964 · PMC5136710
Verification
verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Authors declared no conflicts; NIH (NCATS) grant.

2. Research question

Is wheat sensitivity without coeliac disease associated with systemic immune activation and intestinal epithelial damage?

3. Study design and population

Study design
Case-control study – Case-control biomarker study
Population

People reporting wheat-related symptoms with coeliac disease and wheat allergy excluded; coeliac patients; healthy controls

Country

not stated in abstract (US-funded investigators)

Period

not stated in abstract

Sample size

not stated in abstract

Inclusion and exclusion criteria

Coeliac disease and wheat allergy ruled out in the wheat-sensitive group

4. Methods and endpoints

Exposure / intervention

Self-reported wheat sensitivity

Comparator

Healthy controls; coeliac patients

Endpoints

Serum sCD14, LPS-binding protein, anti-LPS and anti-flagellin antibodies, FABP2

Statistical methods

Group comparisons; correlation

5. Actual results

Results

Wheat-sensitive individuals had significantly increased sCD14, LPS-binding protein, antibody reactivity to LPS and flagellin, and FABP2 (marker of epithelial cell damage); markers moved toward normal in a subgroup after excluding wheat and related cereals.

Absolute risks

not reported

Authors' conclusion

A state of systemic immune activation with compromised intestinal epithelium affects a subset of people with wheat sensitivity without coeliac disease.

6. Strengths

  • Objective serum biomarkers
  • Includes coeliac and healthy comparison groups

7. Weaknesses

  • Not blinded challenge; self-selected cases
  • Cross-sectional, so cause and effect unclear
  • Sample sizes not in abstract

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Selection of cases and possible confounding; biomarker specificity uncertain.

9. Assessment of the statistical interpretation

Shows group differences in biomarkers, not that wheat (or gluten specifically) causes them.

10. Relevance to the specific claim

Contradicts the sweeping claim that no wheat/gluten sensitivity exists: a subgroup shows objective abnormalities.

11. Independent contrary findings

I-GRN-101, I-GRN-102 (blinded challenges mostly negative).

12. Transferability to Germany and Europe

Moderate to high.

13. Overall methodological judgement

Suggestive biological evidence for a subset; not replicated in large blinded studies.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsnot applicable
Directnessdirect
Reproducibilitynot replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Replication; which wheat component is responsible.

15. Linked fact checks